Correlation of post SARS-COV-2 infection gut microbiome and gastrointestinal symptoms in pediatric and adolescent population
Correlation of post SARS-COV-2 infection gut microbiome and gastrointestinal symptoms in pediatric and adolescent population
-
Clinical Trial Information
Trial Contact: Winbigler, Holly M; Roppo, Emily
Trial Phone: 321,841,9560 ; 321.841.9560
-
IRB No: 230.018.01
Protocol Abbrev: Long Covid
Principal Investigator: Darlene Barrett Antonio, PhD
Age Group: Pediatric
-
Objective
To compare the gut microbiome composition and diversity of post-COVID-19 infection with the gut microbiome of healthy age-matched group collected before the pandemic start in 2020. To assess the gut microbiome in patients, post COVID-19 virus infection cases and correlate with the presented gastrointestinal symptoms such as stress, anxiety, and symptoms.
-
Key Eligibility
The targeted study population will include any child or young adult between the age 8 and 21, who tested positive for COVID-19 and hospitalized from the disease in ORMC or APH. Patients with COVID-19 and Multisystem Inflammation Syndrome in children (MIS-C) will be included.
